Search

everythinglearnresearchcommunity

for

Search:↓

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Mutations in certain receptors can cause diseases and offer new treatment options.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Vitamin C was found to effectively treat prickly heat in children.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

The hairpiece matted due to weathered hair after shampooing.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.